Prime-Boost: Oncolytic Virotherapy in Combination with Tumor Vaccines for Durable Anti-Tumor Immunity
Time: 1:40 pm
day: Day One
Details:
• How oncolytic virotherapy can alter TME to create a favorable immune environment for secondary therapeutic targeting
• How tumor cell lysis releases entire spectrum of tumor neoantigens and expands TCR repertoire for broader antigen recognition by the immune system in preparation for vaccine administration
• How the prime-boost regime can create a durable anti-tumor response to combinations of virotherapy with tumor vaccines
